ASTRO   |   RT Answers

Demonstrating the Value of RT

SherHeadshotROI awarded David Sher, MD, MPH, a grant to conduct the study "Comparative Value of Transoral Surgery and Radiation for Oropharynx Cancer" (OPC).

In this ROI-funded grant, Dr. Sher is:

  • Comparing survival, toxicity and accrued costs of surgery versus radiotherapy and chemoradiotherapy for patients with OPC using data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER)-Medicare database and the HealthCore Integrated Research Database (HIRD).
  • Analyzing the data for early-stage and locally advanced OPC separately.
  • Expecting the analysis to provide important information on the comparative effectiveness and relative costs of these competing modalities.

Dr. Sher and his team are working on several manuscripts to be published in the next year.